|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 295.52 USD | -1.55% |
|
+0.35% | -16.25% |
| 06-30 | United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says | MT |
| 06-30 | UBS Adjusts Price Target on United Therapeutics to $385 From $410, Maintains Buy Rating | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.55% | +0.35% | +5.03% | +5.96% | -16.25% | -10.24% | +21.03% | +151.63% | +72.24% | 13.54B | ||
| +0.30% | +1.58% | -1.76% | +10.00% | +2.72% | -15.62% | +139.96% | +385.44% | +798.19% | 710B | ||
| -0.50% | +0.57% | +0.29% | +5.52% | +8.49% | +5.00% | -11.99% | +10.21% | +57.64% | 379B | ||
| -1.31% | +1.67% | +1.56% | +10.48% | +8.30% | +14.46% | +25.91% | +98.75% | +177.99% | 344B | ||
| -3.64% | +0.24% | -15.55% | +7.18% | -29.68% | -55.03% | +9.87% | +103.29% | +128.38% | 317B | ||
| -2.36% | -0.31% | -4.82% | +5.68% | +0.51% | +3.13% | -20.22% | -22.66% | -6.31% | 265B | ||
| -3.00% | -0.59% | -1.37% | +13.60% | +8.49% | -2.11% | +16.28% | +17.35% | -1.25% | 244B | ||
| -1.66% | +2.41% | -3.88% | +4.31% | -0.17% | -13.48% | -5.38% | +22.87% | +143.90% | 223B | ||
| -0.79% | +3.00% | +2.47% | +7.49% | -16.20% | -34.52% | -10.15% | +8.64% | +43.85% | 211B | ||
| -1.70% | -1.00% | +0.63% | +4.93% | +13.29% | -8.21% | +18.83% | +18.56% | +91.61% | 162B | ||
| -0.50% | +1.06% | +5.56% | +18.81% | -3.32% | -9.52% | -51.76% | -24.18% | -25.35% | 147B | ||
| -4.28% | -1.89% | -0.41% | +8.13% | +18.70% | +59.48% | +74.47% | +43.66% | -3.60% | 142B | ||
| -2.23% | +2.01% | +3.84% | -1.40% | +16.43% | -4.63% | +59.32% | +59.23% | +281.33% | 123B | ||
| -1.34% | +0.68% | -5.21% | -6.76% | -11.43% | -11.25% | -16.41% | -6.62% | -10.21% | 120B | ||
| -3.42% | -0.13% | -6.22% | -7.13% | -17.15% | +13.96% | -37.83% | -18.41% | -32.35% | 98.74B | ||
| -3.16% | +1.04% | -6.63% | +10.47% | +4.60% | -6.41% | -35.79% | -28.46% | -17.75% | 79.82B | ||
| -0.32% | -2.83% | -10.70% | +1.77% | -2.31% | +6.91% | +86.96% | +26.66% | +374.24% | 77.08B | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | ||
| -1.22% | +8.44% | +3.21% | +17.32% | +23.97% | +44.38% | +47.98% | -31.27% | +305.96% | 53.63B | ||
| +0.97% | -1.02% | +0.30% | +6.26% | +4.71% | +3.01% | +12.72% | +19.29% | -26.22% | 46.76B | ||
| Average | -1.37% | +1.71% | -1.77% | +6.45% | +0.72% | -1.09% | +17.04% | +43.89% | +123.80% | 190.99B | |
| Weighted average by Cap. | -1.39% | +1.32% | -2.26% | +7.38% | +0.56% | -6.39% | +31.17% | +96.05% | +216.76% |
- Stock Market
- Equities
- UTHR Stock
- Sector United Therapeutics Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition